News and Events
The University of Minnesota College of Pharmacy mourns the loss of Don Uden, PharmD, professor in the Department of Pharmaceutical Care & Health Systems, who died on Saturday, March 21.
The University of Minnesota College of Pharmacy has ranked third in this year’s U.S.News and World Report’s ranking of pharmacy schools.
Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.
This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations.
David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.
Samuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.
Welocome to our newest member, Debra Skaar, PharmD, FCCM. She is an Associate Professor in Experimental and Clinical Pharmacology. Read her hio here.
Jay's research focuses on the determination of known genetic variations within Very Important Pharmacogenes (VIPs) in the Hmong population which brings local, state-wide and regional relevance to the nationally supported NIH “Precision Medicine Initiative”.
U scientists are teaming up with the Mille Lacs Band of Ojibwe to investigate aspects of lung cancer and nicotine metabolism from commercial tobacco use that may be unique to the American Indian populations.
This two-day conference will provide PGx implementation education on a range of topics through lectures and smaller group breakout sessions. Registration opens on January 15, 2020.
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.